Supernus Pharmaceuticals (SUPN) Operating Income (2011 - 2026)
Supernus Pharmaceuticals (SUPN) reported Operating Income of -$57.96 million for Q2 2026, compared with $12.14 million a year earlier.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Operating Income (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Supernus Pharmaceuticals' Operating Income came in at -$109.99 million; for FY2025, it was -$62.28 million.
- By year, Operating Income came in at $81.67 million in FY2024, -$5.27 million in FY2023, $46.12 million in FY2022 (-46.4%) and $86.03 million in FY2021 (-50.5%).
- Five-year quarterly Operating Income spans a low of -$60.23 million in Q3 2025 and a high of $40.85 million in Q3 2024.
- The high point for year-over-year Operating Income in five years was Q4 2022 (growth of 463.0%); the low point was Q4 2021 (a decline of 85.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Supernus Pharmaceuticals | 2.45 Bn | 1.11 Bn | 185.39 Mn | -57.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -57.96 Mn |
| Dec 31, 2025 | -3.94 Mn |
| Sep 30, 2025 | -60.23 Mn |
| Jun 30, 2025 | 12.14 Mn |
| Mar 31, 2025 | -10.26 Mn |
| Dec 31, 2024 | 21.41 Mn |
| Sep 30, 2024 | 40.85 Mn |
| Jun 30, 2024 | 22.57 Mn |
| Mar 31, 2024 | -3.15 Mn |
| Dec 31, 2023 | -996,000.00 |
| Sep 30, 2023 | 8.14 Mn |
| Jun 30, 2023 | -17.59 Mn |
| Mar 31, 2023 | 5.18 Mn |
| Dec 31, 2022 | 34.33 Mn |
| Sep 30, 2022 | -1.52 Mn |
| Jun 30, 2022 | 11.35 Mn |
| Mar 31, 2022 | 1.97 Mn |
| Dec 31, 2021 | 6.10 Mn |
| Sep 30, 2021 | 32.60 Mn |
| Jun 30, 2021 | 34.11 Mn |
API Access
Supernus Pharmaceuticals Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();